AS-601245

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAS-601245
Drug Alias NameAS-601245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase 3 inhibitorsc-Jun N-terminal kinase 1 inhibitorsc-Jun N-terminal kinase 2 inhibitors
Targetsc-Jun N-terminal kinase 1c-Jun N-terminal kinase 2c-Jun N-terminal kinase 3
Therapy Area/IndicationsIschemiaInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono
Active IndicationsN/A
Inactive IndicationsIschemiaInflammation

Other Information

ATC CodeN/A
Related LinksN/A